Consider Akynzeo for Highly Emetogenic Chemotherapy

Akynzeo (ah-KIN-zee-oh) will be a new ORAL antiemetic combo to prevent chemotherapy-induced nausea and vomiting.

Akynzeo combines the 5-HT3 antagonist, palonosetron (Aloxi), with a new long-acting neurokinin-1 (NK-1) antagonist, netupitant. Think of netupitant as an alternative to aprepitant (Emend).

NK-1 antagonists boost the efficacy of 5-HT3 antagonists to prevent nausea and vomiting.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote